Skip to main content

Jim Cramer Wants This Commitment From Johnson & Johnson On COVID-19 Vaccine

Publish date:
Video Duration:

Let's talk about Johnson & Johnson.

The company submitted an application seeking emergency use authorization for its investigational single-dose COVID-19 vaccine candidate to the U.S. Food and Drug Administration.

Johnson & Johnson said that its EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the Janssen investigational single-dose vaccine met all primary and key secondary endpoints. JNJ said it expects to have product available to ship immediately following authorization.

Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.

You can follow Jim Cramer and Katherine Ross on Twitter at @JimCramer and @byKatherineRoss. Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer:

Related Videos